Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 11 - 15 tags : Phase 1 save search
AnaptysBio Announces Positive Rosnilimab Healthy Volunteer Phase 1 Top-Line Data
Published: 2021-11-15 (Crawled : 14:00) - ir.anaptysbio.com
ANAB | $19.66 -1.06% -1.09% 140K
|
Health Technology
|
| O: -0.27%
H: 0.0%
C: 0.0%
phase 1 positive topline phase 2 phase 3
Oncternal Therapeutics Presented Updated Interim Phase 1/2 Clinical Trial Data for ONCT-216 in Patients with Relapsed/Refractory Ewing Sarcoma at CTOS 2021 Virtual Annual Meeting
Published: 2021-11-15 (Crawled : 13:30) - globenewswire.com
ONCT | $8.55 -3.5% 4.12% 0
|
Health Technology
|
| O: -0.25%
H: 0.0%
C: 0.0%
ewing sarcoma phase 1 trial
Rocket Pharmaceuticals Announces Positive Updates from Phase 1 Clinical Trial of RP-A501 in Danon Disease
Published: 2021-11-15 (Crawled : 13:00) - biospace.com/
RCKT M | $23.87 4.69% 4.64% 47
|
Health Technology
|
| O: -1.63%
H: 0.0%
C: -23.94%
disease phase 1 positive trial phase 2 phase 3 rp-a501 danon disease
Addex Strategic Partner Successfully Completes Phase 1 in Japan with ADX71149
Published: 2021-11-15 (Crawled : 09:00) - biospace.com/
JNJ | News | $149.12 0.82% 0.59% 440K
|
Health Technology
|
| O: -1.36%
H: 0.0%
C: 0.0%
ADXN | $19.28 -3.84% -10.32% 6.2K
|
Health Technology
|
| O: 2.85%
H: 1.14%
C: 1.14%
phase 1 phase 2 xin phase 3
Gainers vs Losers
| 72% | 28% |
Top 10 Gainers
AGBA | $2.5 100.0% 58.33% 200M
|
Finance
EDBL | News | $6.26 66.49% 48.56% 270K
|
SMFL | $4.35 29.2% 47.55% 4.2M
|
Manufacturing
MLEC | $2.47 76.43% 38.05% 460K
|
n/a
PEGY | $0.0458 -10.2% 28.77% 79M
|
Manufacturing
PROK | $2.72 33.33% 26.88% 20K
|
PALI | $4.93 4.67% 25.83% 2.1M
|
Manufacturing
SGD | $0.685 -1.71% 22.48% 2M
|
n/a
SILO | $1.99 0.71% 20.64% 1.8M
|
Finance and Insurance
NNVC | $1.12 1.82% 19.64% 2.5K
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.